Vardenafil
| Clinical data | |
|---|---|
| Trade names | Levitra, Staxyn, Vivanza |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a603035 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 15% |
| Protein binding | 95% |
| Metabolism | Liver (CYP3A4) |
| Elimination half-life | 4–5 hours |
| Excretion | Bile duct |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.112.672 |
| Chemical and physical data | |
| Formula | C23H32N6O4S |
| Molar mass | 488.61 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Vardenafil, sold under the brand name Levitra among others, is a medication that is used for treating erectile dysfunction. It is a PDE5 inhibitor. It is taken by mouth.